NEW DELHI: Country’s apex drug regulator has approved human trials of Covid-19 vaccine candidate indigenously developed by Hyderabad based Biological E.
This is the fifth potential Covid-19 vaccine permitted for clinical trial in India, days after Dr Reddy’s Laboratories. received a go-ahead to carry out phase 2 and 3 trials in the country.
The subject expert committee under the Central Drugs Standard Control Organisation on Covid-19 gave its approval on Monday after analysing the data from the pre-clinical trials or animal studies.
“After detailed deliberation, the committee recommended for grant of permission to conduct the Phase I/ II trial,” said the SEC.
The vaccine maker will now soon start the phase 1 and 2 trial of the vaccine but as of now it has not divulged any detail related to the vaccine candidate or trial.